BIVDA - The British In Vitro Diagnostic Association

In vitro diagnostics (IVDs) test a sample of tissue or bodily fluid in an effort to diagnose a disease or condition. Effectively used, IVDs help to reduce hospital stays, support patients to look after their own health and release resources for use elsewhere in the NHS, resulting in a healthier population and stronger economic growth.

BREXIT Contingency Planning Enquiries

BIVDA would like to help any members who seek clarification on the likely impact of a no-deal Brexit on the shipment of medical goods, however the volatility and uncertainty of the situation makes it impossible for us to give any definitive information. We have been involved in meetings and discussions with the DHSC MDCC EU Exit Contingency Team however, and they have given us a contact address as below:

Where can I find more information and ask questions?

For any further queries, please do not hesitate to contact us via email at mdcc-contingencyplanning@dhsc.gov.uk. Information about EU Exit can also be accessed via the gov.uk website: https://www.gov.uk/government/publications/medical-devices-and-clinical-consumables-no-deal-brexit-preparation-plans-update

Industry

Find out more about how BIVDA represents the IVD industry on behalf of its members. You can also access our Events Diary and Members’ Area. If you are not already a member, discover how you can ‘join us’!

Healthcare Professionals

If you are a healthcare professional, please click here to find out more about the value of IVDs and how they can deliver improved outcomes for patients and the NHS.

The Value of IVDs

Ever wondered what an IVD is? Want to know more about how diagnostics are helping patients? Keen to discover more about the role of the industry? You can find out the answer to all of these questions and more, here.

Latest Blog

Increased funding is not enough to sustain the NHS. We need to make better use of in vitro diagnostics to ensure a successful future - After months of speculation, the Prime Minister finally unveiled her long-awaited birthday present for the NHS yesterday. While the promise of additional funding is always welcome, many questions remain unanswered, including: how will the increase be funded? How will the money be spent? Will the money be enough?

Latest Report

Three simple tests could save the NHS at least £6.9 billion - Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) reveals that the NHS could save over £6.9 billion in five years through quick adoption of new diagnostic tests as they come onto the market. In turn, these savings could help tackle the annual NHS shortfall, widely expected to reach £20 billion by 2022

Download Here

BIVDA meeting dates

5 February - External Affairs WP

7 February - Market Dynamics Group

27 February - Near Patient Testing

5 March - Procurement WP

7 March - Executive Board

14 March - AGM

22 March - Regulatory Affairs WP

More Events

IMPORTANT UPDATE:

As of 1st October, BIVDA has a new email domain.
The convention for our new email addresses is [first name]@bivda.org.uk. This also applies to our enquiries@bivda.org.uk address.

All other contact information for us remains the same:

Website: www.bivda.org.uk

LinkedIn: British In Vitro Diagnostics Association

Twitter: @BIVDA

Tel.: 0845 6188 224

Please update your records with our new contact information. If you have any questions, please contact the BIVDA team at any time.